Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1808.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,667.0,1.0,=,2.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1260.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,460.0,1.0,=,2.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2651.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,1541.0,1.0,=,1.7
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3242.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,1691.0,1.0,=,1.9
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2270.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,2005.0,1.0,=,1.1
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2610.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,1172.0,1.0,=,2.2
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1215.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,398.0,1.0,=,3.1
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1046.0,1.0,Epsilon,13,S13I + W152C + L452R,1,=,523.0,1.0,=,2.0